Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Example of Drug Shortage Information and Links
National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information:
| Temporary Situational Shortages | |
| IV Fluids (250-1000 mL) | Baxter’s manufacturing plant in North Carolina experienced extensive damage in the wake of flooding generated by Hurricane Helene. This plant is the primary manufacturing site for large-volume IV fluids (LVPs), irrigation fluids, and dialysis fluids. Fluid types impacted include sodium chloride, lactated ringers. The shortage of LVPs is having extensive downstream effects on small-volume IV fluids and on several premixed bags. Refer to this link to get the most recent updates provided by Baxter. |
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| fluorescein ophthalmic strips | Supply is limited. Est. release: none. |
| hydroxocobalamin 5g injectable | Supply is limited. Est. release: none. |
| methylprednisolone 2 mg tablets | Supply in pharmacy is depleted. Estimated release: May 2025 |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| miconazole vaginal suppository | Supply in pharmacy is depleted. Est. release: none. |
| perflutren (Optison) | Supply in pharmacy is limited. Purchasing on allocation. |
| sodium bicarbonate injectable | Supply of manufacturer 50ml syringes is limited in pharmacy; 10ml syringes are depleted. Vial supply is unaffected. Estimated release for 10ml syringes: Jan 2026. |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| basiliximab injectable | Pharmacy has adequate supply to meet needs. |
| indocyanine green injectable | Pharmacy has adequate supply to meet needs. |
| isosorbide mononitrate IR tablets | Supply is critical in pharmacy. Estimated release: none. Extended-release products are currently unaffected. |
| penicillin G benzathine injectable | Pharmacy has adequate supply to meet needs. |
| remifentanil injectable | Pharmacy has adequate supply to meet needs. |
| rifaximin 200 mg tablets | Pharmacy has adequate supply to meet needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| activated charcoal pellets | Supply in pharmacy is critical. All pellet charcoal products have been discontinued. |
| atropine-diphenoxylate | The oral suspension has been discontinued; there are no manufacturers actively making this product. Pharmacy supply is depleted. |
| lindane products | All presentations have been discontinued FDA Orange Book |
| mafenide acetate powder for solution | All topical solutions have been discontinued FDA Orange Book |
| methyldopa tablets | All presentations have been discontinued FDA Orange Book |
| nicotine inhalation system |
|
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |